Systemic lupus erythematosus (SLE) is an autoimmune inflammatory disease characterized
by the presence of a plethora of autoantibodies and immune complex formation. Virtually …

In this review of the gastrointestinal (GI) and hepatic manifestations of systemic lupus
erythematosus (SLE), 180 articles from the English literature, found using a medline search …

Systemic lupus erythematosus (SLE) is a multisystem disorder which can affect the
gastrointestinal (GI) system. Although GI symptoms can manifest in 50% of patients with …

Systemic lupus erythematosus (SLE) is a fairly common rheumatic disease among southern
Chinese in Hong Kong, with an estimated point prevalence of 0.06%(0.1% among women) …

Gastrointestinal (GI) symptoms are common in patients with systemic lupus erythematosus
(SLE) and may be due to the disease itself, side-effects of medications, or non-SLE causes …

Approximately 10% to 25% of all patients with rheumatologic disorders visiting the
emergency department require hospital admission [1–3], and up to one third of the …

In an autoimmune disease, the immune system attacks and harms the body's own tissues.
The systemic autoimmune diseases include collagen vascular diseases, the systemic …

Gastrointestinal (GI) manifestations of systemic lupus erythematosus (SLE) are protean. Any
part of the GI tract and the hepatobiliary system can be involved. Up to two-third of SLE …

This study was performed to investigate the clinical characteristics of lupus enteritis in
Japanese patients with systemic lupus erythematosus (SLE). A total of 481 patients with SLE …

Objective. To analyze the epidemiology, clinical characteristics, and risk factors for systemic
lupus erythematosus-related intestinal pseudo-obstruction (SLE-IPO). Methods. We …